NCT07065318

Brief Summary

Lung transplantation is a crucial surgical intervention aimed at increasing survival rates in patients with end-stage lung diseases such as chronic obstructive pulmonary disease (COPD), cystic fibrosis, idiopathic pulmonary fibrosis, and pulmonary hypertension. One of the most important determinants of health outcomes before and after lung transplantation is exercise capacity. An increase in the 6-minute walking distance (6MWD), which serves as a measure of functional exercise capacity, is associated with lower mortality rates in both pre- and post-transplantation settings. Therefore, effective rehabilitation programs are needed to enhance the exercise capacities of lung transplant candidates. Pulmonary rehabilitation (PR) is a comprehensive program designed specifically for individuals with chronic respiratory diseases. PR aims to improve patients\' physical and psychological conditions through detailed assessments and personalized treatment plans. It can play a role in enhancing the preoperative exercise capacities of lung transplant candidates and improving their chances of successful health outcomes. However, lung transplant candidates often have more advanced lung disease and face greater challenges compared to typical patients undergoing PR, making the expected benefits more complex to achieve. The primary aim of this study is to investigate the effects of high-intensity interval training (HIIT) in lung transplant candidates with interstitial lung disease (ILD). The first objective is to compare the physiological responses and effectiveness of HIIT and moderate-intensity continuous training (MICT) within the same exercise volume. The secondary aim is to evaluate the impact of HIIT on body structure and function, activity, and participation levels using ICF-based assessments.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2024

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

November 21, 2024

Completed
8 months until next milestone

First Posted

Study publicly available on registry

July 15, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

July 15, 2025

Status Verified

July 1, 2025

Enrollment Period

1.2 years

First QC Date

November 21, 2024

Last Update Submit

July 3, 2025

Conditions

Keywords

lung transplant candidatesexercise traininghigh intensity interval trainingaerobic exercise

Outcome Measures

Primary Outcomes (2)

  • Cardiopulmonary exercise capacity

    Peak Work Rate (PWR) PWR is determined through a symptom-limited incremental bicycle ergometer test. Patients pedal at 10 W, increasing by 10 W each minute until fatigue or a workload of 50 W is reached, or a fatigue level of 9 on the modified Borg scale. Workload and heart rate are monitored, with maximum workload (Wpeak) and heart rate recorded at the end.

    through study completion, an average of 1 year

  • Submaximal exercise capacity

    -Minute Walk Test (6MWT) The 6MWT assesses exercise capacity in a 30-meter corridor by measuring the distance walked. It evaluates oxygen saturation, heart rate, and dyspnea using the Borg scale before and after the test. Participants walk at their own pace and can pause or use oxygen as needed.

    through study completion, an average of 1 year

Secondary Outcomes (9)

  • Forced Expiratory Volume in 1 Second (FEV1) Measured by Spirometry (Liters)

    through study completion, an average of 1 year

  • Fragility

    through study completion, an average of 1 year

  • Life Quality

    through study completion, an average of 1 year

  • Kinesiophobia

    through study completion, an average of 1 year

  • Muscle strength

    through study completion, an average of 1 year

  • +4 more secondary outcomes

Study Arms (2)

LV-HIIT (Low-Volume High-Intensity Interval Training)

EXPERIMENTAL

The first randomly assigned group will perform 30 seconds of high-intensity exercise at 85-100% of their maximum workload, followed by 30 seconds of exercise at 40% of their maximum workload. This 30-second high-intensity exercise followed by 30 seconds of low-intensity exercise will be referred to as one cycle. A total of 20 cycles will be completed. Additionally, 2 minutes of low-intensity warm-up and cool-down exercises will be performed.

Behavioral: LV-HIIT (Low-Volume High-Intensity Interval Training)Device: Ergometer cycle

MICT (Moderate-Intensity Continuous Training)

ACTIVE COMPARATOR

The second group determined as a result of randomization will exercise for 20-30 minutes at 60-80% of maximum workload. Exercise volume (duration × %Wpeak) matched between groups.

Behavioral: MICT (Moderate-Intensity Continuous Training)Device: Ergometer cycle

Interventions

30-sec intervals at 85-100% peak workload, 30-sec rest at 40%, total 20-30 min.

LV-HIIT (Low-Volume High-Intensity Interval Training)

Continuous cycling at 60-80% peak workload for 20-30 min.

MICT (Moderate-Intensity Continuous Training)

Electronically Ergometer cycle custo ec5000, CustoMed used for all exercise sessions. Calibrated before each trial.

LV-HIIT (Low-Volume High-Intensity Interval Training)MICT (Moderate-Intensity Continuous Training)

Eligibility Criteria

Age18 Years - 64 Years
Sexall(Gender-based eligibility)
Gender Eligibility Detailsmen and women
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Being diagnosed with interstitial lung disease and being followed up at the Ankara City Hospital Chest Diseases Clinic,
  • Being 18 years of age or older,
  • Patients who are being followed up with a diagnosis of ILD according to the ATS/ERS 2022 international ILD guideline,
  • Being on the lung transplant waiting list according to the International Society for Heart and Lung Transplantation and are being evaluated for listing and are being followed up by the chest diseases department (25-28),
  • Being willing to participate in the exercise program regularly and volunteering to participate in the study,
  • Patients who have dyspnea levels of 2 and above according to the Modified Medical Research Council dyspnea scale and are able to ambulate,
  • Patients who receive long-term oxygen support will be included.

You may not qualify if:

  • Patients with a history of exertional syncope,
  • Patients in acute exacerbation,
  • Patients with sarcoidosis,
  • Patients with serious comorbidities that may limit exercise (e.g. musculoskeletal, neurological or cardiovascular problems) will not be included.
  • Patients with an aortic aneurysm greater than 5.5 cm,
  • Patients with cardiovascular impediments to exercise during cardiological evaluations prior to pulmonary rehabilitation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Bilkent City Hospital

Ankara, Ankara, 06000, Turkey (Türkiye)

RECRUITING

Related Publications (1)

  • Hume E, Ward L, Wilkinson M, Manifield J, Clark S, Vogiatzis I. Exercise training for lung transplant candidates and recipients: a systematic review. Eur Respir Rev. 2020 Oct 28;29(158):200053. doi: 10.1183/16000617.0053-2020. Print 2020 Dec 31.

    PMID: 33115788BACKGROUND

Study Officials

  • Hatice K Kılıc, Prof. Dr.

    Ankara City Hospital Bilkent

    STUDY CHAIR
  • Ebru CK Calık Kutukcu, Prof. Dr.

    Hacettepe University

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: There will be 2 groups in the study. Group 1 will do low volume high-intensity interval exercise training. Group 2 will receive moderate-intensity continuous aerobic exercise training.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 21, 2024

First Posted

July 15, 2025

Study Start

November 1, 2024

Primary Completion

January 1, 2026

Study Completion

January 1, 2026

Last Updated

July 15, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations